Latest BioNTech/Pfizer vaccine to arrive in Luxembourg late next week

9 月 14, 2022World News

© AFP (Archiv)

This vaccine was specifically adapted for the BA4 and BA5 Omicron variants and was recommended for approval in the EU on Monday.

At the earliest, the first deliveries of the latest coronavirus vaccine developed by BioNTech/Pfizer are expected to arrive late next week, otherwise early the following week. High Commissioner for National Security Luc Feller confirmed this to our colleagues from upon enquiry. BA5 is currently the most prevalent coronavirus variant in Luxembourg.

Last week, the Grand Duchy already received deliveries of adjusted coronavirus vaccines from BioNTech/Pfizer and Moderna. The 85,700 doses are being used for booster shots as of this week. These vaccines were developed on the basis of the BA1 Omicron variant.

Read more
Related Content:Interferon response induced by Omicron BA.1 and BA.5 prevents influenza A infection


The Covid sales boom is over for Pfizer

Pfizer generated nearly $57 billion in combined sales last year from its Comirnaty Covid-19 vaccine and Paxlovid antiviral pill. That works out to almost 60% of the company’s total revenue for 2022. But the boom appears to be over. Pfizer (PFE) told Wall Street...

Opinion: The real problem with sick leave in America

Editor’s Note: Kara Alaimo, an associate professor in the Lawrence Herbert School of Communication at Hofstra University, writes about issues affecting women and social media. Her book, “This Feed Is on Fire: Why Social Media Is Toxic for Women and Girls — And How We...

About Us

Taiwan Cloud Environmental Technology Co., Ltd


HeadOffice:2F, No. 128, 1st sec. Freedom Road, Taichung403, Taiwan.

TEL:+886 4 22257222